Promoter Bank clone, Human p14 alternative reding frame (ARF) promoter
Alternative name | p1923-23F |
---|---|
Clone info. | PCR amplified human p14 alternative reding frame (ARF) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Genomic sequence of 4728nt to 5703nt of AF082338.1 corresponding -922 to +54 (tanscription start site is designated +1. Fig.2B of Robertson, KD., Mol. Cell. Biol. 18 (11): 6457-6473, 1998) was PCR-amplified and then cloned. |
Comment | PCR cloning, forward primer, C7PB0051F: 5' agcgctcagatgctccgcggctg 3'; reverse primer, C7PB0051R: 5' gagctcggcagccgctgcgccg 3'. |
Vector backbone | pKM2L (RDB04026) (Plasmid) |
Size of vector backbone | 4.2 kb |
Selectable markers | Kan^r |
Gene/insert name | Human p14 alternative reding frame (ARF) genomic DNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05510 | pKM2L-phP14ARF | DNA solution |
Materials & Methods section:
The pKM2L-phP14ARF was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05510). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB05510_A8Bmp1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 () Sequence file: RDB05510_A8Bma.seq |
---|
>05510_05510_A8Bm_M13_-40_A01_01_ABI08.ab1 1 AAGCCAGGGC AAGCTTGGCA TGCCTGCAGG TCATTTAAAT AGGGATAACA GGGTAATGAT 61 TAAGATCTCG AGCTCTAAGC TTCACATATG CATGCACTAG TGGCGGTGCT CAGATGCTCC 121 GCGGCTGTCG TGAAGGTTAA AACCGAAAAT AAAAATGGGC TAGACACAAA GGACTCGGTG 181 CTTGTCCCAG CCAGGCGCCC TCGGCGACGC GGGCAGCTGG GAGGGGAATG GGCGCCCGGA 241 CCCAGCTGGG ACCCCCGGGT GCGACTCCAC CTACCTAGTC CGGCGCCAGG CCGGGTCGAC 301 AGCTCCGGCA GCGCCAGCGC CGCGCCGTGT CCAGATGTCG CGTCAGAGGC GTGCAGCGGT 361 TTAGTTTAAT TTCGCTTGTT TTCCAAATCT AGAAGAGGAG CGGAGCGGCT TTTAGTTCAA 421 AACTGACATT CAGCCTCCTG ATTGGCGGAT AGAGCAATGA GATGACCTCG CTTTCCTTTC 481 TTCCTTTTTC ATTTTTAAAT AATCTAGTTT GAAGAATGGA AGACTTTCGA CGAGGGGAGC 541 CAGGAATAAA ATAAGGGGAA TAGGGGAGCG GGGACGCGAG CAGCACCAGA ATCCGCGGGA 601 GCGCGGCTGT TCCTGGTAGG GCCGTGTCAG GTGACGGATG TAGCTAGGGG GCGAGCTGCC 661 TGGAGTTGCG TTCCAGGCGT CCGGCCCCTG GGCCGTCACC GCGGGGCGCC CGCGCTGAGG 721 GTGGGAAGAT GGTGGTGGGG GTGGGGATCA TCTGG // |
Primer: phRLR2 () Sequence file: RDB05510_A8Bmb.seq |
>05510_05510_A8Bm_phRLR2_B01_02_ABI08.ab1 1 AACATTCCTT TGTTTGACAA GCCCAGTTTC TATTGGTCTC CTTAAACCTG TCTTGTAACC 61 TTGATACTTA CCTGCCCAGT GCCTCACGAC CAACTTCTGC AGTACCCGGG TGAATTCTAC 121 GCGTCGACAG GCGAGCTCGG CAGCCGCTGC GCCGCCCTTT GGCACCAGAG GTGAGCAGCG 181 CCACTCCTGC CCCCTTAACT GCAGACTGGG ACCCACGCAC CGCCCCCTGC CCATCTCCGC 241 CCCGCAGGCG CGCACCCGCC TTCCCTGAGC GCGCCCGCCC CCCACCTTCA CCCCCACCCC 301 CACCCCACCC CCACTCCCAC CCGGACCTCC AAGATCTCGG AACGGCTCTG AGCCCTGCGC 361 ACGCGGGAAG GGCTGCCGGA GGCGCCCGTA GGGAGGCGCG CGCGCGGGCG GCTCAGGGCC 421 CGCGTTCCTC TCCCTCCCGC CTACCGCCAC TTTCCCGCCC TGTGTGCGCC CCCACCCCCA 481 CCACCATCTT CCCACCCTCA GCGCGGGCGC CCCGCGGTGA CGGCCCAGGG GCCGGACGCC 541 TGGAACGCAA CTCCAGGCAG CTCGCCCCCT AGCTACATCC GTCACCTGAC ACGGCCCTAC 601 CAGGAACAGC CGCGCTCCCG CGGATTCTGG TGCTGCTCGC GTCCCCGCTC CCCTATTCCC 661 CTTATTTTAT TCCTGGCTCC CCTCGTCGAA AGTCTTCCAT TCTTCAAACT AGATTATTTA 721 AAAATGAAAA AGGAAGAAAG GAAAGCGAGG TCATCTCATT GCTCTATCCG CCAATCAGGA 781 GGCTGAATGT CAGTTTTGAA CTAAAAGCCG CTCCGCTCCT CTTCTAGATT TGGAAAACAA 841 GCGAAATTAA ACTAAACCGC TGCACGCCTC TGACGCGACA TCTGGACACG GCGCGGCGCT 901 GGCGCTGCCG GAGCTGTCGA CCCGGCCTGG CGCCGGACTA GGTAGGTGGA GTCGCACCCG 961 GGGGGTCCCA GCTGGGTCCG GGCGCCCATT CCCCTCCCAG CTGCCCGCGT CGCCGAGGGC 1021 GCCTGCTGGG ACAAGCACCG AGTCCCTTTG GTGTCTAGCC CAATTTTTAT TTTCGGTTTT 1081 AAACGTCACG GACAGCCGGC GGAGCCATCC TGAAGCACGG TCACTAGTGC AATGCCATAT 1141 GTGAAGCTTT AGAGCCTCGA AGAATCCTTA AATCCAGA // |
Primer: pAxCALNL_F1 () Sequence file: RDB05510_A8Bmc.seq |
>05510_05510_A8Bm_pAxCALNL_F1_C01_03_ABI08.ab1 1 AAGTGATCTT ATATGTCTGC TCGAGCGGCC GCTCTAGAAT TACTGCTCGT TCTTCAGCAC 61 GCGCTCCACG AAGCTCTTGA TGTACTTACC CATTTCATCT GGAGCGTCCT CCTGGCTGAA 121 GTGGAGGCCC TTCACCTTCA CGAACTCGGT GTTAGGGAAC TTCTTAGCTC CCTCGACAAT 181 AGCGTTGGAA AAGAACCCAG GGTCGGACTC GATGAACATC TTAGGCAGAT CGTCGCTGGC 241 CCGAAGGTAG GCGTTGTAGT TGCGGACAAT CTGGACGACG TCGGGCTTGC CTCCCTTAAC 301 GAGAGGGATC TCGCGAGGCC AGGAGAGGGT AGGCCGTCTA ACCTCGCCCT TCTCCTTGAA 361 TGGCTCCAGG TAGGCAGCGA ACTCCTCAGG CTCCAGTTTC CGCATGATCT TGCTTGGGAG 421 CATGGTCTCG ACGAAGAAGT TATTCTCAAG CACCATTTTC TCGCCCTCTT CGCTCTTGAT 481 CAGGGCGATA TCCTCCTCGA TGTCAGGCCA CTCGTCCCAG GACTCGATCA CGTCCACGAC 541 ACTCTCAGCA TGGACGATGG CCTTGATCTT GTCTTGGTGC TCGTAGGAGT AGTGAAAGGC 601 CAGACAAGCC CCCCAGTCGT GGCCCACAAA GATGATTTTC TTTGGAAGGT TCAGCAGCTC 661 GAACCAAGCG GTGAGGTACT TGTAGTGATC CAGGAGGCGA TATGAGCCAT TCCCGCTCTT 721 GCCGGACTTA CCCATTCCGA TCAGATCAGG GATGATGCAT CTAGCCACGG GCTCGATGTG 781 AGGCACGACG TGCCTCCACA GGTAGCTGGA GGCAGCGTTA CCATGCAGAA AAATCACGGC 841 GTTCTCGGCG TGCTTCTCGG AATCATAGTA GTTGATGAAA GGAGTCCAGC ACGTTCATTT 901 GCTTGCAGCG AGCCCACCAC TGAGGCCCAG TGATCATGCG TTTGCGTTGC TCGGGGGTCG 961 TACACCTTGG AAAGCCATGG GTGGGCTAGC CTATAGTGAG TCGTATTTAA AGTACTCTAG 1021 GCCTTAAGAG GCTTGTTAAT TTGAACTGGG GAGGTGGAAC ACCTGTTGGG AGAGAAAAGG 1081 CAAAGTGGGA TGTAAGTAAA GACCAATAGG TTGCTTATCA GGAACGCAGG AGTCGTCTCT 1141 GGTCTCGACA AAGCCCAGTT TCTTATTTGG TCTTTA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content